{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:56:32Z","timestamp":1782867392567,"version":"3.54.5"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.virol.2019.09.005","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T08:06:46Z","timestamp":1568362006000},"page":"24-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Development of a novel screening platform for the identification of small molecule inhibitors of human adenovirus"],"prefix":"10.1016","volume":"538","author":[{"given":"Bratati","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Varette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Simon","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2019.09.005_bib1","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3389\/fmicb.2016.01503","article-title":"Components of adenovirus genome packaging","volume":"7","author":"Ahi","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2019.09.005_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1189\/jlb.71.1.9","article-title":"Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor","volume":"71","author":"Almawi","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.virol.2019.09.005_bib3","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.3390\/ijms19082154","article-title":"The antiviral effects of Na,K-ATPase inhibition: a minireview","volume":"19","author":"Amarelle","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virol.2019.09.005_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01089-17","article-title":"Adenovirus core protein VII downregulates the DNA damage response on the host genome","volume":"91","author":"Avgousti","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.09.005_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.ge.20.120186.000401","article-title":"Adenovirus promoters and E1A transactivation","volume":"20","author":"Berk","year":"1986","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.virol.2019.09.005_bib6","series-title":"Fields Virology","first-page":"2355","article-title":"Adenoviridae: the viruses and their replication","author":"Berk","year":"2007"},{"key":"10.1016\/j.virol.2019.09.005_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2017.02.008","article-title":"Fatal adenovirus infection in an immunocompetent host","volume":"35","author":"Bhatti","year":"2017","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.virol.2019.09.005_bib8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.15585\/mmwr.mm6639a2","article-title":"Human adenovirus surveillance - United States, 2003-2016","volume":"66","author":"Binder","year":"2017","journal-title":"MMWR (Morb. Mortal. Wkly. Rep.)"},{"key":"10.1016\/j.virol.2019.09.005_bib9","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1128\/JVI.02417-08","article-title":"Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation","volume":"83","author":"Blackford","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.09.005_bib10","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1128\/AAC.04348-14","article-title":"Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients","volume":"59","author":"Caruso Brown","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2019.09.005_bib11","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1128\/jvi.70.7.4805-4810.1996","article-title":"Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli","volume":"70","author":"Chartier","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.09.005_bib12","unstructured":"ClinicalTrialsgov, Administration of Virus-specific Cytotoxic T-Lymphocytes (NCT00590083)."},{"key":"10.1016\/j.virol.2019.09.005_bib121","unstructured":"ClinicalTrialsgov, Clinical Grade Adenovirus Specific T Cells for Immunotherapy after Allogeneic Stem Cell Transplantation (NCT02851576)."},{"key":"10.1016\/j.virol.2019.09.005_bib13","doi-asserted-by":"crossref","first-page":"10715","DOI":"10.1128\/JVI.01050-16","article-title":"Convallatoxin-induced reduction of methionine import effectively inhibits human cytomegalovirus infection and replication","volume":"90","author":"Cohen","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.09.005_bib14","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1093\/nar\/gkg405","article-title":"DNA binding properties of the adenovirus DNA replication priming protein pTP","volume":"31","author":"de Jong","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2019.09.005_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.antiviral.2016.12.017","article-title":"Discovery of host-targeted covalent inhibitors of dengue virus","volume":"139","author":"de Wispelaere","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2019.09.005_bib16","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1097\/MPH.0000000000001227","article-title":"Brincidofovir (CMX001) toxicity associated with epithelial apoptosis and crypt drop out in a hematopoietic cell transplant patient: challenges in distinguishing drug toxicity from GVHD","volume":"40","author":"Detweiler","year":"2018","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.virol.2019.09.005_bib17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/s41598-018-37249-4","article-title":"Molecular evolution of human adenovirus (HAdV) species C","volume":"9","author":"Dhingra","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2019.09.005_bib18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.virol.2007.05.001","article-title":"Inhibitors of the sodium potassium ATPase that impair herpes simplex virus replication identified via a chemical screening approach","volume":"366","author":"Dodson","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.virol.2019.09.005_bib19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2165\/00003495-197306030-00005","article-title":"Clinical pharmacology and therapeutics use of digitalis glycosides","volume":"6","author":"Doherty","year":"1973","journal-title":"Drugs"},{"key":"10.1016\/j.virol.2019.09.005_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2013.05.007","article-title":"Identification of novel small molecule inhibitors of adenovirus gene transfer using a high throughput screening approach","volume":"170","author":"Duffy","year":"2013","journal-title":"J. Control. Release : Off. J. Control. Release. Soc."},{"key":"10.1016\/j.virol.2019.09.005_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40360-015-0012-2","article-title":"Effects of cytarabine on activation of human T cells - cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid","volume":"16","author":"Ersvaer","year":"2015","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.virol.2019.09.005_bib22","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1126\/science.1155546","article-title":"Epigenetic reprogramming by adenovirus e1a","volume":"321","author":"Ferrari","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.virol.2019.09.005_bib23","series-title":"Adenoviruses: Basic Biology to Gene Therapy","first-page":"17","author":"Flint","year":"1999"},{"key":"10.1016\/j.virol.2019.09.005_bib24","doi-asserted-by":"crossref","first-page":"10a","DOI":"10.1016\/S0735-1097(85)80458-7","article-title":"Cellular mechanism of action of cardiac glycosides","volume":"5","author":"Fozzard","year":"1985","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.virol.2019.09.005_bib25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrm827","article-title":"Adenovirus-5 E1A: paradox and paradigm","volume":"3","author":"Frisch","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.virol.2019.09.005_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01623-16","article-title":"Suppression of adenovirus replication by cardiotonic steroids","volume":"91","author":"Grosso","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.09.005_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.antiviral.2018.09.015","article-title":"A standardized approach to the evaluation of antivirals against DNA viruses: orthopox-, adeno-, and herpesviruses","volume":"159","author":"Hartline","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2019.09.005_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2045-3701-3-22","article-title":"Inhibition of HIV replication in vitro by clinical immunosuppressants and chemotherapeutic agents","volume":"3","author":"Hawley","year":"2013","journal-title":"Cell Biosci."},{"key":"10.1016\/j.virol.2019.09.005_bib29","first-page":"183","article-title":"Recovery of new agent from patients with acute respiratory illness","volume":"vol.85","author":"Hilleman","year":"1954"},{"key":"10.1016\/j.virol.2019.09.005_bib30","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.1155544","article-title":"Adenovirus small e1a alters global patterns of histone modification","volume":"321","author":"Horwitz","year":"2008","journal-title":"Science"},{"issue":"Suppl. 1","key":"10.1016\/j.virol.2019.09.005_bib31","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1002\/jgm.495","article-title":"Function of adenovirus E3 proteins and their interactions with immunoregulatory cell proteins","volume":"6","author":"Horwitz","year":"2004","journal-title":"J. Gene Med."},{"key":"10.1016\/j.virol.2019.09.005_bib32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.1972.03190320021007","article-title":"Cytarabine for herpesvirus infections","volume":"219","author":"Hryniuk","year":"1972","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.virol.2019.09.005_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005471","article-title":"FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection","volume":"5","author":"Johansen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virol.2019.09.005_bib34","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3201\/eid2204.151403","article-title":"Severe infections with human adenovirus 7d in 2 adults in family, Illinois, USA, 2014","volume":"22","author":"Kajon","year":"2016","journal-title":"Emerg. Infect. Dis. J."},{"key":"10.1016\/j.virol.2019.09.005_bib35","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/bjd.14369","article-title":"Cutaneous involvement of disseminated adenovirus infection in an allogeneic stem cell transplant recipient","volume":"174","author":"Keyes","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.virol.2019.09.005_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00390-18","article-title":"Hacking the cell: network intrusion and exploitation by adenovirus E1A","volume":"9","author":"King","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.virol.2019.09.005_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/rmv.386","article-title":"The impact of adenovirus infection on the immunocompromised host","volume":"13","author":"Kojaoghlanian","year":"2003","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virol.2019.09.005_bib38","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1093\/nar\/9.18.4709","article-title":"Aphidicolin inhibits DNA synthesis by DNA polymerase alpha and isolated nuclei by a similar mechanism","volume":"9","author":"Krokan","year":"1981","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2019.09.005_bib39","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2217\/pgs.09.118","article-title":"Genetic factors influencing cytarabine therapy","volume":"10","author":"Lamba","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.virol.2019.09.005_bib40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/rmv.589","article-title":"Clinical features and treatment of adenovirus infections","volume":"18","author":"Lenaerts","year":"2008","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virol.2019.09.005_bib41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/CMR.00116-13","article-title":"Adenovirus infections in immunocompetent and immunocompromised patients","volume":"27","author":"Lion","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.virol.2019.09.005_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.antiviral.2017.12.019","article-title":"A high throughput screen identifies benzoquinoline compounds as inhibitors of Ebola virus replication","volume":"150","author":"Luthra","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2019.09.005_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.antiviral.2018.09.011","article-title":"Inhibition of adenovirus infection by mifepristone","volume":"159","author":"Marrugal-Lorenzo","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2019.09.005_bib44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2162-3619-2-20","article-title":"Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia","volume":"2","author":"Momparler","year":"2013","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.virol.2019.09.005_bib45","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1158\/1535-7163.MCT-07-0108","article-title":"Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus","volume":"6","author":"Nun","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.virol.2019.09.005_bib46","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/nar\/26.5.1240","article-title":"Adenovirus DNA polymerase: domain organisation and interaction with preterminal protein","volume":"26","author":"Parker","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2019.09.005_bib47","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.chembiol.2004.01.018","article-title":"Identification of a small molecule that inhibits herpes simplex virus DNA polymerase subunit interactions and viral replication","volume":"11","author":"Pilger","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.virol.2019.09.005_bib48","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nrd2682","article-title":"Novel therapeutic applications of cardiac glycosides","volume":"7","author":"Prassas","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virol.2019.09.005_bib49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcv.2017.09.013","article-title":"Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir - case series and 10 year experience of management in an adult transplant cohort","volume":"96","author":"Ramsay","year":"2017","journal-title":"J. Clin. Virol. : Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"10.1016\/j.virol.2019.09.005_bib50","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0042-6822(83)90274-X","article-title":"Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNA-binding protein","volume":"128","author":"Reich","year":"1983","journal-title":"Virology"},{"key":"10.1016\/j.virol.2019.09.005_bib51","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jpeds.2013.11.009","article-title":"Neonatal adenoviral infection: a seventeen year experience and review of the literature","volume":"164","author":"Ronchi","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.virol.2019.09.005_bib52","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1128\/JVI.01787-10","article-title":"Assembly of helper-dependent adenovirus DNA into chromatin promotes efficient gene expression","volume":"85","author":"Ross","year":"2011","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2019.09.005_bib53","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot5011","article-title":"Construction and characterization of adenovirus vectors","volume":"2009","author":"Ross","year":"2009","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.virol.2019.09.005_bib54","first-page":"570","article-title":"Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture","volume":"vol.84","author":"Rowe","year":"1953"},{"key":"10.1016\/j.virol.2019.09.005_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181012","article-title":"Human adenovirus type 5 vectors deleted of early region 1 (E1) undergo limited expression of early replicative E2 proteins and DNA replication in non-permissive cells","volume":"12","author":"Saha","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2019.09.005_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00088-19","article-title":"Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses human adenovirus gene expression and replication","volume":"93","author":"Saha","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.09.005_bib57","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.3390\/v6093563","article-title":"The adenovirus genome contributes to the structural stability of the virion","volume":"6","author":"Saha","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2019.09.005_bib58","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1021\/acs.jmedchem.6b00300","article-title":"New 4-Acyl-1-phenylaminocarbonyl-2-phenylpiperazine derivatives as potential inhibitors of adenovirus infection. Synthesis, biological evaluation, and structure-activity relationships","volume":"59","author":"Sanchez-Cespedes","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virol.2019.09.005_bib59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.antiviral.2014.05.010","article-title":"Inhibition of adenovirus replication by a trisubstituted piperazin-2-one derivative","volume":"108","author":"Sanchez-Cespedes","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2019.09.005_bib60","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/j.1460-2075.1987.tb02467.x","article-title":"Differential splicing yields novel adenovirus 5 E1A mRNAs that encode 30 kd and 35 kd proteins","volume":"6","author":"Stephens","year":"1987","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2019.09.005_bib61","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nbt1187","article-title":"An in vitro fluorescence screen to identify antivirals that disrupt hepatitis B virus capsid assembly","volume":"24","author":"Stray","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virol.2019.09.005_bib62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2008.01.156","article-title":"Anti-HSV activity of digitoxin and its possible mechanisms","volume":"79","author":"Su","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2019.09.005_bib63","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0092-8674(80)90362-1","article-title":"DNA replication and the early to late transition in adenovirus infection","volume":"22","author":"Thomas","year":"1980","journal-title":"Cell"},{"key":"10.1016\/j.virol.2019.09.005_bib64","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1128\/jvi.70.4.2296-2306.1996","article-title":"The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells","volume":"70","author":"Tollefson","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.09.005_bib65","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2018.01.014","article-title":"Retinoic acid receptor beta, a potential therapeutic target in the inhibition of adenovirus replication","volume":"152","author":"Wang","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2019.09.005_bib66","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2741\/1604","article-title":"Functions of the adenovirus E4 proteins and their impact on viral vectors","volume":"10","author":"Weitzman","year":"2005","journal-title":"Front. Biosci. : J. Vis. Lit."},{"key":"10.1016\/j.virol.2019.09.005_bib67","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1093\/emboj\/cdg614","article-title":"Switch from capsid protein import to adenovirus assembly by cleavage of nuclear transport signals","volume":"22","author":"Wodrich","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2019.09.005_bib68","article-title":"Adenovirus-mediated expression of the p14 fusion-associated small transmembrane protein promotes cancer cell fusion and apoptosis in vitro but does not provide therapeutic efficacy in a xenograft mouse model of cancer","volume":"11","author":"Wong","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2019.09.005_bib69","doi-asserted-by":"crossref","first-page":"7171","DOI":"10.1128\/AAC.03860-14","article-title":"Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters","volume":"58","author":"Ying","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2019.09.005_bib70","first-page":"213","article-title":"The structure and function of the adenovirus major late promoter","volume":"272","author":"Young","year":"2003","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virol.2019.09.005_bib71","doi-asserted-by":"crossref","first-page":"11006","DOI":"10.1128\/JVI.77.20.11006-11015.2003","article-title":"Strategic attack on host cell gene expression during adenovirus infection","volume":"77","author":"Zhao","year":"2003","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682219302624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682219302624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:49:21Z","timestamp":1758588561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682219302624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":72,"alternative-id":["S0042682219302624"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2019.09.005","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a novel screening platform for the identification of small molecule inhibitors of human adenovirus","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2019.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}